Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,895 | 151 | 95.8% |
| Travel and Lodging | $127.53 | 1 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $596.50 | 29 | $0 (2023) |
| DePuy Synthes Sales Inc. | $281.77 | 12 | $0 (2024) |
| UCB, Inc. | $278.46 | 13 | $0 (2023) |
| Pacira Pharmaceuticals Incorporated | $251.72 | 6 | $0 (2024) |
| Horizon Pharma plc | $232.80 | 23 | $0 (2018) |
| Arbor Pharmaceuticals, Inc. | $225.66 | 15 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $223.44 | 11 | $0 (2021) |
| Celgene Corporation | $100.18 | 1 | $0 (2017) |
| Bioventus LLC | $90.21 | 5 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $70.81 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $154.76 | 8 | DePuy Synthes Sales Inc. ($49.95) |
| 2023 | $602.85 | 21 | Pacira Pharmaceuticals Incorporated ($229.48) |
| 2022 | $194.73 | 10 | Amgen Inc. ($91.86) |
| 2021 | $561.91 | 30 | Amgen Inc. ($152.40) |
| 2020 | $299.00 | 17 | Arbor Pharmaceuticals, Inc. ($73.81) |
| 2019 | $252.07 | 14 | Amgen Inc. ($108.84) |
| 2018 | $472.42 | 28 | DePuy Synthes Sales Inc. ($176.21) |
| 2017 | $484.41 | 24 | Horizon Pharma plc ($109.54) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Avanos Medical | TRIVISC SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/19/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Sports Early Intervention | ||||||
| 09/13/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 08/20/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: OSTEOARTHRITIS | ||||||
| 06/12/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 05/08/2024 | DePuy Synthes Sales Inc. | MONOVISC (Device), ORTHOVISC | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Sports Early Intervention | ||||||
| 04/05/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Pain Management | ||||||
| 03/21/2024 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ORTHOPEDICS | ||||||
| 12/02/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: non-opioid analgesic | ||||||
| 11/15/2023 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $31.72 | General |
| Category: Inflammation | ||||||
| 11/08/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Bone Health | ||||||
| 10/28/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Pain Management | ||||||
| 10/28/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Pain Management | ||||||
| 10/27/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | In-kind items and services | $127.53 | General |
| Category: Pain Management | ||||||
| 10/27/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $41.45 | General |
| Category: Pain Management | ||||||
| 10/05/2023 | Bioventus LLC | GELSYN-3 (Device) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Not Applicable | ||||||
| 09/20/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Immunology | ||||||
| 09/15/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device), Zilretta | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Pain Management | ||||||
| 08/02/2023 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: OSTEOPOROSIS | ||||||
| 07/12/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Rare Disease | ||||||
| 06/28/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Interventional Urology | ||||||
| 06/21/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $22.11 | General |
| Category: Not Applicable | ||||||
| 06/13/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Immunology | ||||||
| 05/31/2023 | Ethicon US, LLC | N/A (Device) | Food and Beverage | In-kind items and services | $42.03 | General |
| Category: Endo-Mechanical | ||||||
| 05/16/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 829 | 12,109 | $1.1M | $234,688 |
| 2022 | 12 | 702 | 12,115 | $929,551 | $295,170 |
| 2021 | 13 | 897 | 11,296 | $920,847 | $338,773 |
| 2020 | 13 | 917 | 6,020 | $662,308 | $200,570 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | Office | 2023 | 76 | 6,520 | $338,520 | $74,656 | 22.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 140 | 683 | $193,734 | $52,841 | 27.3% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 43 | 3,336 | $333,600 | $44,510 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 430 | $98,860 | $38,926 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 80 | $18,924 | $5,144 | 27.2% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 87 | 143 | $18,304 | $4,875 | 26.6% |
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 18 | 21 | $35,910 | $3,560 | 9.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $6,140 | $2,899 | 47.2% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 16 | 16 | $25,760 | $2,535 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,120 | $1,547 | 49.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 33 | 34 | $4,590 | $936.53 | 20.4% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 26 | 32 | $3,040 | $855.16 | 28.1% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 17 | 22 | $2,970 | $799.11 | 26.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 100 | 744 | $22,320 | $602.78 | 2.7% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2022 | 68 | 5,280 | $360,000 | $127,159 | 35.3% |
| J7331 | Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | Office | 2022 | 52 | 4,860 | $225,990 | $68,645 | 30.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 118 | 619 | $176,250 | $47,616 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 310 | $48,050 | $29,609 | 61.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 144 | $15,270 | $9,096 | 59.6% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2022 | 19 | 19 | $30,590 | $3,155 | 10.3% |
| 73721 | Mri scan of leg joint without contrast | Office | 2022 | 16 | 18 | $30,780 | $2,708 | 8.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $6,200 | $2,697 | 43.5% |
| 73564 | X-ray of knee, 4 or more views | Office | 2022 | 51 | 72 | $9,216 | $2,365 | 25.7% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 20 | 32 | $3,040 | $856.84 | 28.2% |
| 72114 | X-ray lower and sacral spine, minimum of 6 views | Office | 2022 | 13 | 13 | $2,925 | $636.23 | 21.8% |
About Dr. Ashish Vala, M.D
Dr. Ashish Vala, M.D is a Family Medicine healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225267412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashish Vala, M.D has received a total of $3,022 in payments from pharmaceutical and medical device companies, with $154.76 received in 2024. These payments were reported across 152 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,895).
As a Medicare-enrolled provider, Vala has provided services to 3,345 Medicare beneficiaries, totaling 41,540 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Sports Medicine
- Location Sugar Land, TX
- Active Since 07/08/2009
- Last Updated 05/29/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1225267412
Products in Payments
- Enbrel (Biological) $435.36
- Cimzia (Drug) $278.46
- Iovera (Device) $229.48
- Horizant (Drug) $225.66
- COSENTYX (Biological) $223.44
- Otezla (Drug) $206.77
- MONOVISC (Device) $159.56
- VIMOVO (Drug) $152.33
- ORTHOVISC (Device) $122.21
- EUFLEXXA (Device) $70.81
- AUTOFILL (Device) $67.00
- HYMOVIS (Device) $57.58
- RAYOS (Drug) $56.23
- SAPHNELO (Biological) $54.18
- N/A (Device) $42.03
- EVENITY (Biological) $37.24
- PENNSAID (Drug) $36.97
- GELSYN 3 (Device) $35.22
- GELSYN-3 (Device) $32.34
- Zilretta (Drug) $29.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sugar Land
Wilner Jeudy, Md, MD
Family Medicine — Payments: $243,277
Dr. Carl Meisner, Md, MD
Family Medicine — Payments: $116,479
Anne Ponce De Leon, Md, MD
Family Medicine — Payments: $75,166
Hammad Zaidi, M.d, M.D
Family Medicine — Payments: $49,687
John Vanderzyl, Md, MD
Family Medicine — Payments: $21,283
James Trippett, Md, MD
Family Medicine — Payments: $20,590